Company Monitoring Page for Sandoz

latest headlines for company on cafepharma

Novartis copy of Amgen biotech drug shows similar efficacy-study
Yahoo/Reuters
Mon, 12/8/14 - 08:24 am
Tags:
Novartis, Amgen, Neupogen, biosimilars, Sandoz, neutropenia
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Tags:
Sandoz, psoriasis, Amgen, Enbrel, generics
Amgen and Sandoz Square Off Over a Biosimilar Application
WSJ Pharmalot
Mon, 11/3/14 - 11:45 am
Tags:
Amgen, Sandoz, biosimilars, Neupogen
Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft
FDA Law Blog
Thu, 10/30/14 - 05:43 pm
Tags:
Amgen, Sandoz, Neupogen, biosimilars
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Fri, 08/8/14 - 09:34 am
Tags:
biosimilars, Sandoz, Novartis, FDA
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Mon, 07/21/14 - 10:43 am
Tags:
Allergan, layoffs, Anacor, Sinovac Biotech, Kerydin, earnings, China, Sandoz, vaccines
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thu, 06/19/14 - 05:47 pm
Tags:
NUVIGIL, patents, Teva Pharmaceuticals, Sandoz, Apotex, Mylan Labs, Actavis, Lupin
What Will Happen When Biotech Drugs Go Generic?
Forbes
Fri, 06/13/14 - 10:58 am
Tags:
biotech, generics, Amgen, Roche, Biogen Idec, Eli Lilly, Bristol-Myers Squibb, Sanofi, Novartis, Sandoz, Omnitrope, Genotropin
Acura Pharma announces settlement of patent litigation with Sandoz
The Fly on the Wall
Thu, 05/22/14 - 08:28 am
Tags:
Sandoz, Novartis, Acura Pharmaceuticals, patents, Aversion, Oxceta
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thu, 05/15/14 - 07:35 am
Tags:
Teva, FDA, generics, Copaxone, Mylan Labs, Novartis, Sandoz, multiple sclerosis
Drugmakers Oppose Teva Bid to Delay Copaxone Rivals
Bloomberg
Mon, 04/14/14 - 07:08 pm
Tags:
Teva, Copaxone, MS, multiple sclerosis, Momenta, generics, Sandoz, Mylan
Novartis names two new leaders to growth drivers Alcon, Sandoz
Fierce Pharma
Wed, 04/9/14 - 09:43 pm
Tags:
Alcon, Sandoz, Novartis
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Mon, 03/31/14 - 11:00 am
Tags:
Supreme Court, MS, multiple sclerosis, Copaxone, Teva Pharmaceuticals, Sandoz, Mylan, Momenta
Novartis CEO predicts generic industry fallout as quality takes center stage
Fierce Pharma Manufacturing
Fri, 03/21/14 - 08:48 am
Tags:
Sandoz, Novartis, Joe Jimenez, generics, drug manufacturing
Cadence: Patent Settlement With Sandoz Increases Confidence That Ofirmev Will Have Exclusivity Through December 6, 2020
Seeking Alpha
Fri, 01/31/14 - 08:45 am
Tags:
Cadence Pharmaceuticals, Sandoz, Ofirmev, Exela Pharma Sciences
Sandoz starts late-stage trial with copy of AbbVie's Humira drug
Yahoo/AP
Wed, 12/18/13 - 05:14 pm
Tags:
Sandoz, generics, Humira, AbbVie, biosimilars, Novartis
Shire agrees to supply Adderall XR generic to Sandoz
Reuters
Mon, 12/2/13 - 08:40 am
Tags:
Shire, generics, Sandoz, Novartis, ADHD, Adderall XR
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Mon, 11/25/13 - 09:01 am
Tags:
Europe, JNJ, Novartis, pay-for-delay, generics, Sandoz, Fentanyl, pain patches
Glaxo Declines as FDA Clears Path for Advair Rivals
Bloomberg
Tue, 09/10/13 - 10:41 am
Tags:
GSK, Advair, FDA, COPD, asthma, Sandoz, Actavis, Mylan, generics
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Mon, 06/24/13 - 10:44 am
Tags:
Amgen, Enbrel, generics, Sandoz, Novartis, chronic plaque psoriasis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.